Clinical Trial Update: Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients. [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating spironolactone to reduce perioperative atrial fibrillation in cardiac surgery patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Surgery Complications

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: University Hospital, Caen | Conditions: Cardiac Surgery, Atrial Fibrillation | Phase 3 | Status: UNKNOWN